TCT-87 Frequency And Impact Of Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention In Women Compared To Men: Pooled Analysis From The ACUITY And HORIZONS-AMI Trials  by Schoos, Mikkel et al.
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: The SRI is a newly described method for quantifying the proportion of
CAD burden treated by PCI. Given its correlation with mortality, and pending external
validation, the SRI may be useful in assessing the degree of revascularization after
PCI, with SRI 80% a “reasonable” goal.One-year Outcomes According to SYNTAX Revascularization Index
SRI 100%
SRI 50-
99% SRI <50%
P-value all
groups
Death 15 (1.4) 24 (2.7) 25 (3.7) 0.009
Cardiac death 4 (0.4) 18 (2.0) 13 (1.9) 0.002
Myocardial infarction 75 (7.1) 97 (10.8) 71 (10.4) 0.006
Unplanned
revascularization
109 (11.0) 99 (11.4) 89 (13.4) 0.14
Deﬁnite/probable ST 12 (1.1) 17 (1.9) 13 (2.0) 0.29
Death/ myocardial
infarction
86 (8.2) 110 (12.3) 88 (12.9) 0.001
Major adverse cardiac
events
167 (16.4) 171 (19.2) 144 (21.3) 0.009
Data presented as n (%); Major adverse cardiac events (MACE) is the composite rate of death,
myocardial infarction, or unplanned revascularization. MI¼myocardial infarction;
SRI¼SYNTAX Revascularization Index; ST¼stent thrombosis.TCT-87
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Background: Women have greater morbidity and mortality after myocardial infarc-
tion (MI) than men. Whether this is due to more severe comorbidities or inherent
biologic differences is unsettled. Speciﬁcally, women have been shown to have higher
platelet reactivity, but whether a greater thrombotic tendency contributes to gender
differences in outcome is unknown.
Methods: Intraprocedural Thrombotic Events (IPTE), deﬁned as new/increasing
thrombus, abrupt vessel closure, no/slow reﬂow, or distal embolization, were evalu-
ated in 6,591 patients undergoing stenting in a pooled analysis from the ACUITY and
HORIZONS-AMI trials of patients with non-ST-segment elevation acute coronary
syndromes and ST-segment elevation MI. Quantitative coronary angiographic analysis
was blinded to treatment and outcomes.
Results: IPTE was identiﬁed in 507 patients (7.7%), with 119/1744 (6.8%) occurring
in women and 388/4847 (8.0%) in men (p¼0.12). Rates of MACE (Death, MI, un-
planned target lesion revascularization for ischemia) and major bleeding were higher
in women (p< 0.001) and in patients with IPTE (p< 0.001). However, the risk of
MACE associated with IPTE was nearly identical among women [HR (95%CI) ¼ 1.6
(1.0-2.4), p¼0.03] and men [HR ¼ 1.6 (1.2-2.0), p< 0.001] (Figure). Similar results
were found for major bleeding. There was no interaction between IPTE and gender for
1-year MACE (p¼0.99) and 30-day bleeding (p¼0.50).B26 JACC Vol 64/11/Suppl BConclusions: In acute coronary syndromes, IPTE is not uncommon and occurs at
similar frequency in both men and women. The adverse impact of IPTE on ischemic
and bleeding risk is also independent of sex.
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Background: Several studies showed peri-contrast staining (PSS) after silorimus-
eluting stent was be associated with target-lesion revascularization (TLR) and very
late stent thrombosis. However, the incidence and clinical sequela of PSS after second
generation DES implantation are unclear, so we retrospectively evaluate the clinical
outcomes.
Methods: This study consisted of de novo 2301 lesions in 1743 patients that were
treated with second generation DES (zotarolimus-eluting stent: ZES, everolimus-
eluting stent: EES, and biolimus-eluting stent: BES). They were evaluated by follow-
up angiography within 12 months after stent implantation, from April 2009 to
February 2013. We divided into PSS group and non-PSS group and compared the two
groups in clinical and angiographical outcomes.
Results:We had obtained 1872 lesions follow-up angiography. (81.3%) The mean
clinical follow up period was 61013 days. Baseline clinical and angiographic
characteristics were similar between the two groups. (N.S.) Late acquired PSS
was observed in 16 lesions (0.85%). In these lesions, 2 lesions (0.73%) were
observed in BES, 7 lesions (0.67%) were EES and 7 lesions (1.62%) were ZES.
(N.S.) Stent fracture (SF), tortuosity, and lesions with severe angulation (>45)
were more frequently observed in lesions with PSS than in lesions without PSS
(31.3% versus 1.1%, p< 0.0001, 12.5% versus 1.3%, p¼0.002, 18.8% versus
1.7%, p¼0.02). Cumulative incidence of TLR and MACE in the PSS group
was higher than that in the non-PSS group. ( 33.3% versus 5.4%, p¼0.003, and
41.7% versus 9.3%, p¼0.003). There was no signiﬁcant difference in late and
very late stent thrombosis between the two groups. (N.S.) After multivariable
analysis, CTO (OR: 4.07, 95% CI: 1.1 to 12.1, p¼0.04), and reference diameter
(>2.83mm) (OR: 4.17, 95% CI:1.5 to 12.4, p ¼ 0.005) were independent
predictors for PSS.
Conclusions: PSS after second generation DES was a rare phenomenon but appeared
to be associated with subsequent TLR.
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Background: The left ventricular global function index (LVGFI) is a novel indicator
of left ventricular performance. Its role in patients after acute myocardial infarction is
unknown. We sought to investigate the relationship between the LVGFI and infarct
characteristics as well as left ventricular ejection fraction in patients after acute ST-
segment elevation myocardial infarction (STEMI).
Methods: 226 patients with ﬁrst STEMI (mean age 57  11 years) were enrolled in
this observational study. All patients underwent cardiac magnetic resonance (CMR)
imaging within the ﬁrst week after STEMI. Infarct characteristics were determined
with the use of late gadolinium enhanced images. Left ventricular dimensions and
function were measured by cine true-FISP sequences.
Results: The mean LVGFI was 32  8 %. LVGFI was inversely related with peak
creatine kinase (r ¼ -0.46), peak cardiac troponin T (r ¼ -0.45) and CMR-determined
infarct size (r ¼ -0.42, all p < 0.001). Signiﬁcantly decreased LVGFI values were
also observed in patients with microvascular obstruction and anterior STEMI (all
p < 0.001). In addition, there was a strong correlation between LVGFI and left
ventricular ejection fraction (r ¼ 0.91, p < 0.001).
Conclusions: This study demonstrates that the LVGFI is signiﬁcantly associated
with infarct characteristics and left ventricular ejection fraction in patients after
acute STEMI. LVGFI is a useful functional parameter of the left ventricle.
Future studies are needed to evaluate its role as a prognostic marker in this
population.j September 13–17, 2014 j TCT Abstracts/Angiography and QCA
